Roswell Park and Generate Biomedicines Inc. are collaborating on a new clinical trial designed to overcome key barriers that have limited the success of cellular therapies in ovarian cancer and other ...

GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.

Researchers are studying whether combining CAR-T cell therapy with targeted drugs could help children with high-risk leukemia, including infants whose cancer may be more likely to return after treatme...

Roswell Park Comprehensive Cancer Center unveiled a new and more compact mobile lung cancer screening unit.

Roswell Park investigators to present 21 studies at international meeting

In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major […]

KOMET-007 shows ziftomenib plus venetoclax/azacitidine drives deep MRD-negative remissions in R/R AML, with manageable toxicity and longer responses.